Charles River Laboratories International vs Medpace Holdings

Charles River Laboratories International (CRL), health care, and Medpace Holdings (MEDP), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Medpace Holdings is worth $18.3B on the stock market and Charles River Laboratories International $15.9B: Medpace Holdings is valued at 15% more. Charles River Laboratories International trades at 361 times earnings and Medpace Holdings at 36.3; operating margins in their latest fiscal years were 0.63% and 21.1%. Over the past year Charles River Laboratories International's share price has moved +106% and Medpace Holdings's +9.83%.

Key facts

Charles River Laboratories International market value
$15.9B
Medpace Holdings market value
$18.3B
Charles River Laboratories International P/E
361
Medpace Holdings P/E
36.3
Charles River Laboratories International revenue
$4BFY to 2025-12-27
Medpace Holdings revenue
$2.5BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Charles River Laboratories International vs Medpace Holdings: every measure side by side
Measure Charles River Laboratories International Medpace Holdings
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-272025-12-31
Size
Market cap$15.9Blower$18.3Bhigher
Revenue$4Bhigher$2.5Blower
Earnings-$144.3Mlower$451.1Mhigher
Employees18,300higher6,600lower
Total assets$7.1Bhigher$2Blower
Valuation
P/E361higher36.3lower
P/S4.0lower7.2higher
P/B4.9lower31.2higher
Dividend yield0.00%0.00%
Profitability
Operating margin0.63%lower21.1%higher
Balance sheet
Net assets$3.2Bhigher$459.1Mlower
Total liabilities$3.9Bhigher$1.5Blower
Total debt$2.1B—
Cash on hand$213.8Mlower$497Mhigher
Price change
Today-1.00%lower+0.75%higher
1 year+106%higher+9.83%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Charles River Laboratories International only (7)

Percentages are each holding's share of that investor's reported portfolio. Who owns CRL · Who owns MEDP

Further comparisons

Learn

Questions and answers

Which is bigger, Charles River Laboratories International or Medpace Holdings?

By market value, Medpace Holdings is the larger: $18.3B against $15.9B for Charles River Laboratories International. By revenue in its latest fiscal year, Charles River Laboratories International is the larger: $4B against $2.5B for Medpace Holdings.

Which has the higher P/E ratio?

Charles River Laboratories International: 361, against 36.3 for Medpace Holdings. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Medpace Holdings: 21.1%, against 0.63% for Charles River Laboratories International. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Charles River Laboratories International and Medpace Holdings?

None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Charles River Laboratories International and 7 hold Medpace Holdings.

Cite this page

Funkfolio, “Charles River Laboratories International vs Medpace Holdings”, data as of 18 November 2026. https://funkfolio.com/compare/crl-vs-medp

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.